|
1
|
Carrozzo M, de Uboldi Capei M, Dametto E,
Fasano ME, Arduino P, Broccoletti R, Vezza D, Rendine S, Curtoni ES
and Gandolfo S: Tumor necrosis factor-alpha and interferon-gamma
polymorphisms contribute to susceptibility to oral lichen planus. J
Invest Dermatol. 122:87–94. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Silverman S Jr and Bahl S: Oral lichen
planus update: Clinical characteristics, treatment response, and
malignant transformation. Am J Dent. 10:259–263. 1997.PubMed/NCBI
|
|
3
|
Boyd AS and Nelder KH: Lichen planus. J Am
Acad Dermatol. 25:593–619. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Payeras MR, Cherubini K, Figueiredo MA and
Salum FG: Oral lichen planus: Focus on etiopathogenesis. J Oral
Biol. 58:1057–1069. 2013. View Article : Google Scholar
|
|
5
|
Lodi G, Scully C, Carrozzo M, Griffiths M,
Sugerman PB and Thongprasom K: Current controversies in oral lichen
planus: Report of an international consensus meeting. Part 2.
Clinical management and malignant transformation. Oral Surg Oral
Med Oral Pathol Oral Radiol Endod. 100:164–178. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Matthews JB, Scully CM and Potts AJ: Oral
lichen planus: An immunoperoxidase study using
monoclonal-antibodies to lymphocyte subsets. Br J Dermatol.
111:587–595. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ishii T: Immunohistochemical demonstration
of T cell subsets and accessory cells in oral lichen planus. J Oral
Pathol. 16:356–361. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kilpi AM, Rich AM, Radden BG and Reade PC:
Direct immumofluorescence in the diagnosis of oral mucosal
diseases. Int J Oral Maxillofac Surg. 17:6–10. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sugerman PB, Savage NW and Seymour GJ:
Phenotype and suppressor activity of T-lymphocyte clones extracted
from lesions of oral lichen planus. Br J Dermatol. 131:319–324.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roopashree MR, Gondhalekar RV, Shashikanth
MC, George J, Thippeawamy SH and Shukla A: Pathogenesis of oral
lichen planus-a review. J Oral Pathol Med. 39:729–734. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sugerman PB, Satterwhite K and Bigby M:
Autocytotoxic T-cell clones in lichen planus. Br J Dermatol.
142:449–456. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gu GM, Martin MD, Darveau RP, Truelove E
and Epstein J: Oral and serum IL-6 levels in oral lichen planus
patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
98:637–678. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Lin M, Zhang S, Wang Z, Jiang L,
Shen J, Bai J, Gao F, Zhou M and Chen Q: NF-kappaB-dependent
cytokines in saliva and serum from patients with oral lichen
planus: A study in an ethnic Chinese population. Cytokine.
41:144–149. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hibi M, Nakajima K and Hirano T: IL-6
cytokine family and signal transduction: A model of the cytokine
system. J Mol Med (Berl). 74:1–12. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun A, Chia JS, Chang YF and Chiang CP:
Serum interleukin-6 level is a useful marker in evaluating
therapeutic effects of levamisole and Chinese medicinal herbs on
patients with oral lichen planus. J Oral Pathol Med. 31:196–203.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rhodus NL, Cheng B, Bowles W, Myers S,
Miller L and Ondery F: Proinflammatory cytokine levels in saliva
before and after treatment of (erosive) oral lichen planus with
dexamethasone. Oral Dis. 12:112–116. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mantel N and Haenszel W: Statistical
aspects of the analysis of data from retrospective studies of
disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
|
|
18
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Contemp Clin Trials. 45:139–145. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abdel-Haq A, Kusnierz-Cabala B, Darczuk D,
Sobuta E, Dumnicka P, Wojas-Pelc A and Chomyszyn-Gajewska M:
Interleukin-6 and neopterin levels in the serum and saliva of
patients with lichen planus and oral lichen planus. J Oral Pathol
Med. 43:734–739. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Goel S, Marwah A, Kaushik S, Garg VK and
Gupta S: Role of serum interleukin-6 in deciding therapy for
multidrug resistant oral lichen planus. J Clin Exp Dent.
7:e477–e482. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Toruniowa B, Krasowska D, Kozioł M,
Ksiazek A and Pietrzak A: Serum levels of IL-6 in Mycosis
Fungoides, Psoriasis, and lichen planus. Ann N Y Acad Sci.
762:432–434. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Z, Zhang Q, Wang Y and Zhang W:
Correlations between serum levels of interleukin-2, interleukin-4,
interleukin-6 and clinical sympotoms in patients with oral lichen
planus. J Dent Prev Treat. 12:96–98. 2004.(In Chinese).
|
|
23
|
Wang YM, Fu S, Zhou B, Wang C and Zhou J:
Analysis of Th1/Th2 in the use of hormone therapy in patients with
OLP when T cell response patterns and correlation. Chin J Front Med
Sci (Electronic Version). 6:30–33. 2014.(In Chinese).
|
|
24
|
Kui SU and Hong Xu: The effects of
thymopeptides enteric-coated tablets on oral lichen planus and the
expression of related cytokines. J Pract Stomatol. 30:429–431.
2014.
|
|
25
|
Kishimoto T, Akira S, Narazaki M and Taga
T: Interleukin-6 family of cytokines and Gp130. Blood.
86:1243–1254. 1995.PubMed/NCBI
|
|
26
|
Matsuki Y, Yamamoto T and Hara K:
Detection of inflammatory cytokine messenger-RNA (MRNA)-expressing
cells in human inflamed gingiva by combined in situ hybridization
and immunohistochemistry. Immunology. 76:42–47. 1992.PubMed/NCBI
|
|
27
|
Hirano T, Matsuda T, Turner M, Miyasaka N,
Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldmann M, et al:
Excessive production of interleukin 6⁄B cell stimulatory factor-2
in rheumatoid arthritis. Eur J Immunol. 18:1797–1801. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ridker PM, Cushman M, Stampfer MJ, Tracy
RP and Hennekens CH: Inflammation, aspirin, and the risk of
cardiovascular disease in apparently healthy men. N Engl J Med.
336:973–979. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Moreau P, Harousseau JL, Wijdenes J,
Morineau N, Milpied N and Bataille R: A combination of
anti-interleukin 6 murine monoclonal antibody with dexamethasone
and high-dose melphalan induces high complete response rates in
advanced multiple myeloma. Br J Haematol. 109:661–664. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park MC, Lee SW, Choi ST, Park YB and Lee
SK: Serum leptin levels correlate with interleukin-6 levels and
disease activity in patients with ankylosing spondylitis. Scand J
Rheumatol. 36:101–106. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Packard RR and Libby P: Inflammation in
atherosclerosis: From vascular biology to biomarker discovery and
risk prediction. Clin Chem. 54:24–38. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nishimoto N: Interleukin-6 as a
therapeutic target in candidate inflammatory diseases. Clin
Pharmacol Ther. 87:483–487. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nibali L, Fedele S, D'Aiuto F and Donos N:
Interleukin-6 in oral diseases: A review. Oral Dis. 18:236–243.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Agha-Hosseini F, Mirzaii-Dizgah I, Mikaili
S and Abdollahi M: Increased salivary lipid peroxidation in human
subjects with oral lichen planus. Int J Dent Hyg. 7:246–250. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu JY, Zhang J, Cui JL, Liang XY, Lu R, Du
GF, Xu XY and Zhou G: Increasing CCL5/CCR5 on CD4+ T cells in
peripheral blood of oral lichen planus. Cytokine. 62:141–145. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Agha-Hosseini F and Mirzaii-Dizgah I: p53
as a neoplastic biomarker in patients with erosive and plaque like
forms of oral lichen planus. J Contemp Dent Pract. 14:1–3. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Agha-Hosseini F, Mirzaii-Dizgah I,
Farmanbar N and Abdollahi M: Oxidative stress status and DNA damage
in saliva of human subjects with oral lichen planus and oral
squamous cell carcinoma. J Oral Pathol Med. 41:736–740. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Postal M and Appenzeller S: The role of
Tumor Necrosis Factor-alpha (TNF-α) in the pathogenesis of systemic
lupus erythematosus. Cytokine. 56:537–543. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nibali L, Fedele S, D'Aiuto F and Donos N:
Interleukin-6 in oral disease: A review. Oral Dis. 18:236–243.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yamamoto T, Yoneda K, Ueta E and Osaki T:
Serum cytokines, interleukin-2 receptor, and soluble intercellular
adhesion molecule-1 in oral disorders. Oral Surg Oral Med Oral
Pathol. 78:727–735. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Karagouni EE, Dotsika EN and Sklavounou A:
Alteration in peripheral blood mononuclear cell function and serum
cytokines in oral ichen planus. J Oral Pathol Med. 23:28–35. 1994.
View Article : Google Scholar : PubMed/NCBI
|
